11:11 AM
May 03, 2017
 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic


Cell culture and mouse experiments identified oxyindole-based inhibitors of PGC-1α gluconeogenic activity that could help treat Type II diabetes. High throughput screening of a small molecule library in in vitro and cell-based...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >